BCAT1 and glioblastoma: The authors also found that inhibition of BCAT1 in U-251MG cells diminished glioblastoma cell growth following 7 days exposure of hypoxia, and concluded that hypoxic-induced reprogramming of BCAA metabolism is a key adaptation to maintain glutamate abundance to support cell and tumor growth under hypoxic conditions (140).